Boston Scientific EVP converts 1,171 RSUs to stock

Boston Scientific’s EVP, Global Operations received common shares from RSU conversion, with part of the award used to cover tax or exercise obligations.

Rhea-AI Filing Summary

BOSTON SCIENTIFIC CORP (BSX) reported that EVP, Global Operations Padraig Andrew O'Connor had 1,171 restricted stock units convert into 1,171 shares of common stock on September 2, 2026. Each unit represents a commitment to issue one Boston Scientific share. Of the shares issued, 567 shares were delivered or withheld to pay the exercise price or tax liability, with the remaining shares held directly. Following the transaction, 3,516 restricted stock units remain outstanding and are scheduled to be settled in four equal annual installments beginning on September 2, 2026. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

1,171 shares exercised/converted

Exercise 3 txns

Insider O'Connor Padraig Andrew

Role EVP, Global Operations

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F1, F3	1,171	$0.00	$0.00
Exercise	Common Stock F1, F2	1,171	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	567	$48.37	$27K

Holdings After Transaction: Restricted Stock Units — 3,516 contracts (Direct); Common Stock — 7,892 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
2. F2. Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.
3. F3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant.

Key Figures

Restricted stock units converted: 1,171 units Common shares acquired from RSU conversion: 1,171 shares Shares delivered or withheld: 567 shares +3 more

6 metrics

Restricted stock units converted 1,171 units RSUs converted into common stock on September 2, 2026

Common shares acquired from RSU conversion 1,171 shares Common stock received by the executive on September 2, 2026

Shares delivered or withheld 567 shares Used for payment of exercise price or tax liability

Share value for tax/exercise $48.37 per share Applied to the 567 shares delivered or withheld

RSUs remaining after transaction 3,516 units Restricted stock units held directly following the RSU conversion

RSU expiration date September 2, 2029 Expiration for the reported restricted stock units position

Key Terms

Restricted Stock Units, Employee Stock Purchase Plan, tax liability, Rule 10b5-1

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents the Company's commitment to issue one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Employee Stock Purchase Plan financial

"Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

tax liability financial

"Payment of exercise price or tax liability by delivering or withholding securities"

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for these transactions"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BSX report for EVP Padraig Andrew O'Connor on September 2, 2026?

EVP, Global Operations Padraig Andrew O'Connor had 1,171 restricted stock units convert into 1,171 shares of Boston Scientific common stock on September 2, 2026, as reported in the Form 4.

How many BSX shares were withheld or delivered for tax or exercise obligations in this Form 4?

The filing reports that 567 shares of Boston Scientific common stock were delivered or withheld to pay the exercise price or tax liability, at a reported value of $48.37 per share.

How many restricted stock units does the BSX executive hold after the reported transaction?

After the reported RSU conversion, the executive is shown holding 3,516 restricted stock units, each representing a commitment to issue one share of Boston Scientific common stock in the future.

When will the remaining BSX restricted stock units for this executive be settled into shares?

The remaining restricted stock units are scheduled to be settled in four equal annual installments beginning on September 2, 2026, which is the first anniversary of the date of grant.

Was a Rule 10b5-1 trading plan used for the BSX insider transactions reported here?

No. The filing indicates that the Rule 10b5-1 checkbox is not marked, and there is no footnote stating that the transactions were made under a Rule 10b5-1 trading plan.

What does each BSX restricted stock unit represent in this Form 4 filing?

Each restricted stock unit represents the company’s commitment to issue one share of Boston Scientific common stock to the reporting person, according to the footnote in the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 04:57 PM EDT Accepted by SEC EDGAR 09/03/2026 - 04:34 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Connor Padraig Andrew

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MASSACHUSETTS 01752-1234

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2026		M		1,171	A	$0.0000(1)	8,459(2)	D
Common Stock	09/02/2026		F		567	D	$48.37	7,892	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	09/02/2026		M			1,171	(3)	09/02/2029(3)	Common Stock	1,171	$0.0000	3,516	D

Explanation of Responses:

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

2. Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.

3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant.

	/s/ Susan Thompson, Attorney-in-Fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)